Literature DB >> 26961738

Current treatment approaches and trials in central sleep apnea.

Rami N Khayat1, William T Abraham2.   

Abstract

Central sleep apnea (CSA) is one of the most common comorbidities in patients with heart failure with reduced ejection fraction and is associated with negative consequences. Despite several recent advances, there are currently no widely accepted therapies for CSA. In this review we will discuss available therapies for CSA and review the published trials addressing treatment of CSA in HFrEF patients.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Central sleep apnea; Continuous positive airway pressure; Heart failure; Phrenic nerve stimulation; Sleep apnea

Mesh：

Substances：

Year:  2016        PMID： 26961738     DOI： 10.1016/j.ijcard.2016.02.126

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  3 in total

1.  Effects of Adaptive Servoventilation Therapy for Central Sleep Apnea on Health Care Utilization and Mortality: A Population-Based Study.

Authors:  Meghna P Mansukhani; Bhanu Prakas Kolla; James M Naessens; Peter C Gay; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

Review 2.  Epidemiology of Sleep-Disordered Breathing and Heart Failure: What Drives What.

Authors:  Sushma M Dharia; Lee K Brown
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 3.  Transvenous Phrenic Nerve Stimulation for Central Sleep Apnea: Clinical and Billing Review.

Authors:  Priyanka Heeru Teckchandani; Kimberly Kay Truong; Danielle Zezoff; William J Healy; Rami N Khayat
Journal:  Chest       Date:  2021-11-19       Impact factor: 10.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.